| Code | Description | Claims | Beneficiaries | Total Paid |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
536 |
397 |
$24K |
| 80053 |
Comprehensive metabolic panel |
4,833 |
2,960 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,594 |
3,565 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
111 |
53 |
$6K |
| 81025 |
|
713 |
593 |
$3K |
| 83690 |
|
2,396 |
1,621 |
$3K |
| 82553 |
|
1,422 |
822 |
$3K |
| 87088 |
|
2,289 |
1,788 |
$2K |
| 85730 |
|
1,686 |
1,156 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
693 |
684 |
$899.49 |
| 84484 |
|
527 |
455 |
$843.57 |
| 83880 |
|
146 |
82 |
$774.66 |
| 82962 |
|
439 |
205 |
$730.14 |
| 83735 |
|
574 |
283 |
$622.44 |
| 82550 |
|
844 |
665 |
$594.23 |
| 85610 |
|
866 |
578 |
$478.11 |
| 84145 |
|
101 |
50 |
$404.28 |
| 83605 |
|
183 |
106 |
$311.61 |
| 80047 |
|
193 |
155 |
$267.86 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
36 |
33 |
$215.71 |
| 81002 |
|
500 |
487 |
$200.56 |
| 84703 |
|
154 |
100 |
$185.44 |
| 84100 |
|
290 |
147 |
$175.32 |
| 87186 |
|
110 |
90 |
$161.95 |
| 82803 |
|
78 |
28 |
$157.37 |
| 84702 |
|
57 |
42 |
$146.54 |
| 87076 |
|
114 |
89 |
$133.02 |
| 87040 |
|
74 |
43 |
$120.92 |
| 82140 |
|
38 |
18 |
$93.96 |
| 81015 |
|
154 |
118 |
$68.18 |
| 84443 |
Thyroid stimulating hormone (TSH) |
24 |
24 |
$63.60 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36 |
14 |
$60.76 |
| 87070 |
|
38 |
25 |
$54.89 |
| 82010 |
|
44 |
14 |
$39.70 |
| 86900 |
|
76 |
61 |
$35.10 |
| 87400 |
|
20 |
20 |
$21.90 |
| 86901 |
|
43 |
33 |
$20.58 |
| 85651 |
|
20 |
13 |
$9.40 |